Chest CT
Diagnostic TestRepeated chest CT for automated ILD quantification
NCT Number: NCT06743022
In interstitial lung disease (ILD), the extent of ILD on chest computed tomography (CT) is recognized as an important prognostic factor. Automated tools are now available to quantify ILD, but there is a lack of data on the reproducibility of this measurement and therefore its accuracy.
Therefore, the purpose of this study is to evaluate the variability of automated ILD quantification on chest CT. Reproducibility will be assessed by repeating chest CT scans and using different tools to measure the extent of disease.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
APHP - Bichat Hospital - Pneumology, Paris, IDF, France
In interstitial lung disease (ILD), the extent of ILD on chest computed tomography (CT) is recognized as an important prognostic factor. In recent years, several tools based on texture analysis or deep learning methods have been developed to provide rapid and accurate automated quantification of ILD extent.
An advantage of automated scoring methods is that they theoretically offer perfect repeatability of measurement. However, this is only true if the measurement is repeated on the same images. Several parameters can alter the appearance of the lungs on scanner images, such as the degree of inspiration or the reconstruction kernel used to reconstruct the images. There is a lack of data on the reproducibility of the whole process of automated ILD quantification and therefore its accuracy.
Therefore, the purpose of this study is to evaluate the variability of automated ILD quantification on chest CT.
Reproducibility will be assessed by repeating chest CT scans and using different tools to measure the extent of disease in patients with ILD from 2 institutions. Chest CT will be repeated the same day. This will allow assessment of the variability of automated measurement of ILD extent between 2 CT scans performed on the same day and when using different software. It will also allow to assess the variability of lung volume between the 2 CT scans and the effect of disease (idiopathic pulmonary fibrosis or connective tissue disease-related ILD) on the reproducibility of ILD quantification.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Repeated chest CT for automated ILD quantification
Time frame: Day of inclusion
Reproducibility of ILD quantification on chest CT (as a percentage of lung volume) between two successive scan acquisitions.
Time frame: Day of inclusion
Reproducibility of disease extent measured with different software on the same acquisition
Time frame: Day of inclusion
Reproducibility of total lung volume measured on the scanner between two successive acquisitions
Time frame: Day of inclusion
Reproducibility of disease extension between the two scan acquisitions depending on the disease (idiopathic pulmonary fibrosis or PID secondary to connective tissue disease).
Contact information is provided by the study sponsor or research team.
Guillaume CHASSAGNON, MD, PhD
CONTACT
Marie BENHAMMANI-GODARD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Evaluation of the Reproducibility of the Automated Measurement of the Extent of Interstitial Lung Disease on Chest CT
Acronym: REPRO-PID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06325696
Fibrosis, Idiopathic Pulmonary Fibrosis
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT03297775
Arthritis, Arthritis, Rheumatoid
Aurora, Colorado, United States
View Trial DetailsNCT04664192
Interstitial Lung Disease, Lung Diseases
Dallas, Texas, United States
View Trial DetailsNCT01280994
Interstitial Lung Disease, Lung Diseases
Durham, North Carolina, United States
View Trial Details